Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2020 ,inter alia, to consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2020. We further wish to inform you that in terms of the Company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in securities of the Company has been closed with effect from October 01, 2020 and shall re-open 48 hours after the financial results are made public.
03-11-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 For The Half Year Ended September 30, 2020.

 We are enclosing herewith Compliance certificate under Regulation 7(3) of SEBI (Listing Obligation & Disclosure Requirements) Regulations 2015 for the half year ended September 30, 2020.
30-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Certificate Under Regulation 40(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended September 30, 2020

 We send herewith a certificate for half-year ended September 30, 2020 duly signed by Mr. S.K. Pandey, Practicing Company Secretaries, pursuant to the provisions under Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
28-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholding for the Period Ended September 30, 2020

 Aspira Pathlab & Diagnostics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
20-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation Of Merger Of Sharex Dynamic (India) Private Limited (RTA) With Link Intime India Private Limited And Consequent Name Change Of RTA To 'Link Intime India Private Limited'

 This is to inform you that our Company has received an intimation letter from its Registrar & Transfer Agent (RTA) - 'Sharex Dynamic (India) Private Limited' ('Sharex'), informing the merger of Sharex into its holding Company 'Link Intime India Private Limited' ('Link Intime'), pursuant to scheme of the merger and order dated July 16, 2020, passed by the Regional Director. Link Intime is in the process of filing necessary intimation to the SEBI, Stock Exchanges and Depositories. Pursuant to the merger order, Sharex has now ceased to exist as a separate entity and post-merger the name of our RTA will be 'Link Intime India Private Limited'. Further, all registrar and share transfer assignment pertaining to the Company stands transferred to Link Intime. We request you to take the same on your records.
14-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MAMTA NILESH MAVDesignation :- Company Secretary and Compliance Officer
14-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we are forwarding herewith a copy of the certificate dated October 07, 2020, received from Link Intime India Pvt. Ltd. the Registrar and Transfer Agent of the Company, for the quarter ended September 30, 2020.
14-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window

 The financial results of the Company for the September 30, 2020 will be declared in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the above captioned matter, we would like to inform you that pursuant to the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct for prohibition of insider trading ('Code') the trading window for dealing in securities of the Company will be closed for the purpose of declaration of Financial Results of the Company for the quarter ended September 30, 2020 for all the Designated person of the Company from Thursday, October 01, 2020 and shall open 48 hours after announcement of the financial Results, for all its designated persons.
01-10-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Aspira Pathlab & Diagnostics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
30-09-2020
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

 Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith result of voting (remote e-voting as well as e-voting during AGM) in the prescribed format for the resolutions proposed at the 47th Annual General Meeting. The resolutions have been passed by the shareholders with requisite majority. In accordance with the Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the consolidated voting results of the business transacted at the 47th AGM and the consolidated report of scrutinizers are enclosed as Annexure I and Annexure II.
30-09-2020
Next Page
Close

Let's Open Free Demat Account